Altering gut bacteria with antibiotics reduces inflammation from traumatic brain injuries

A recent study found that a brief course of antibiotics after a head injury can reduce inflammation and tissue damage in the brain. By temporarily altering the community of bacteria living in the digestive tract, the medication appears to help protect the brain during its critical recovery window. These findings were published in the journal Communications Biology.

A traumatic brain injury initiates a cascade of immune responses that affect the entire body. The physical impact damages brain cells, which triggers a localized inflammatory reaction. At the same time, the injury disrupts the delicate ecosystem of microbes living in the digestive system.

This community of bacteria, fungi, and viruses is known as the gut microbiome. The digestive tract and the central nervous system share a continuous line of communication. This connection allows changes in stomach bacteria to influence neurological health and vice versa.

When a physical trauma scrambles this signaling pathway, it can lead to an overactive immune response. This excessive inflammation often worsens the initial brain damage. Over time, repeated injuries can cause progressive deterioration of the sensitive neural tissue.

In medical settings, doctors routinely prescribe antibiotics to brain injury patients to prevent secondary infections. However, the specific effects of these medications on neurological recovery have remained poorly understood. Antibiotics act by eliminating large populations of bacteria in the digestive tract.

The research team wanted to understand how this sudden microbial shift influences the brain’s healing process. The project was led by first author Hannah Flinn and corresponding author Sonia Villapol. Both scientists are affiliated with the Houston Methodist Research Institute in Texas.

Their team sought to determine if preexisting imbalances in gut bacteria affect how the body handles repeated physical traumas. They also wanted to observe whether altering the microbial population could limit progressive brain damage. They designed a series of tests to answer these fundamental biological questions.

To explore these dynamics, the research team designed an experiment using laboratory mice. They divided male mice into groups that received either a single controlled brain injury or two successive injuries. The repeated injuries were spaced just over a month apart to mimic chronic trauma scenarios.

Following the head impacts, some animal groups received a three-day course of broad-spectrum antibiotics in their drinking water. Other animal groups simply drank regular water to serve as a baseline comparison. The researchers then analyzed the animals a few days after the final injury.

The scientists measured the size of the damaged brain tissue and evaluated the levels of localized cell death. The team also examined the activation levels of various immune cells within the brain. To track the digestive changes, they sequenced the bacterial DNA found in the animals’ fecal matter.

They discovered that the antibiotic treatment successfully depleted large portions of the intestinal bacteria. Despite this massive disruption, the mice given the medication displayed improved neurological outcomes. The antibiotic-treated mice exhibited smaller areas of brain tissue damage after repeated injuries.

These treated animals also had fewer dead or dying cells in regions located far from the original impact site. The medication seemingly calmed the aggressive immune response inside the injured brain. Untreated mice displayed high numbers of activated immune cells swarming the injury zone.

These activated immune cells, known as microglia and macrophages, normally clear away debris but can cause collateral damage. In contrast, the mice that drank the antibiotic mixture had far fewer of these inflammatory cells. This subdued immune reaction helped prevent secondary deterioration of the brain.

The researchers originally expected the antibiotics to reduce the production of short-chain fatty acids. These molecules are typically produced by healthy stomach bacteria and are known to lower systemic inflammation. As anticipated, the levels of these beneficial molecules dropped in the treated animals.

Yet, the treated mice still experienced a reduction in brain inflammation. This unexpected outcome led the team to investigate which specific bacteria survived the medication. The DNA sequencing revealed that two particular bacterial strains persisted through the intensive treatment.

These surviving microbes were Parasutterella excrementihominis and Lactobacillus johnsonii. The researchers suspect these specific bacteria might possess unique properties that calm the body’s immune system. By thriving in an empty gut, they might provide an alternative form of neurological protection.

“We found that antibiotic treatment following TBI can reduce harmful gut bacteria, decrease lesion size and limit cell death,” said Villapol. “Our results support a gut–brain mechanism in which microbiome changes influence peripheral immunity and, in turn, neuroinflammation after TBI.”

To confirm that some bacteria are better than no bacteria, the scientists ran a separate test. They observed a special group of mice raised in completely sterile laboratory environments. These isolated animals possess absolutely no digestive microbiome.

When subjected to the same head injuries, these completely sterile mice experienced the most severe neurological decline. The mice lacking a microbiome developed extensive brain lesions. They also exhibited severe neurological inflammation that far exceeded the reactions seen in normally colonized mice.

This comparison demonstrated that entirely removing the intestinal bacteria is highly detrimental. It implies that a complete absence of microbes deprives the immune system of essential regulatory signals. Instead, it is the specific reshaping of the bacterial community that provides protective benefits.

While the brain benefited from the microbial shift, the digestive tract suffered some physical stress. The researchers looked at the intestinal tissue of the treated mice under a microscope. They observed that the microscopic projections lining the gut became shorter and less organized.

The intestinal tissue also lost many of the specialized cells responsible for producing protective mucus. This indicates that the antibiotic therapy comes with an obvious physical cost to the digestive system.

“Our brains are constantly sending signals to the rest of our bodies. Following a traumatic brain event, those signals can get scrambled and disrupt other organs, including our digestive system,” Villapol said. “If the gut stays out of balance, the brain may have a harder time healing.”

The study presents a few limitations that warrant further investigation. The experiments only included male mice, which means the results might not apply equally to females. Hormonal variations and differing immune responses between sexes could alter how the bacterial treatments work.

The researchers acknowledge that future tests must incorporate female subjects to build a complete biological picture. The observation window was also limited to the first few days following the head trauma. The team did not track the animals over long periods to assess lasting cognitive changes.

The delayed effects of heavy bacterial disruption could potentially lead to unforeseen neurological complications months later. Long-term studies are required to verify the safety and durability of this therapeutic approach. In addition, the short-chain fatty acids were only measured in the blood rather than directly inside the intestines.

The researchers caution that doctors should not start prescribing broad-spectrum antibiotics specifically to treat head injuries. Widespread use of these medications can create drug-resistant superbugs and cause severe gastrointestinal side effects. The medical goal is not to wipe out the entire digestive ecosystem.

Instead, scientists hope to isolate the specific mechanisms that provide the protective benefits. Villapol noted that breaking the cycle of acute inflammation could lower the chances of long-term cognitive decline. “If we can break neuroinflammation in the acute or chronic stage, we can reduce the risk of developing Alzheimer’s or dementia,” Villapol said.

Future work will center on the two bacterial strains that survived the medication. The team plans to bioengineer Parasutterella excrementihominis and Lactobacillus johnsonii for targeted medical use. By administering just the helpful bacteria, doctors might eventually be able to treat head injuries safely.

This precision approach could calm the immune system without risking the dangers of widespread microbial destruction. Targeted probiotic therapies could eventually replace the blunt instrument of broad-spectrum antibiotics.

The study, “Antibiotic-induced gut microbiome remodeling reduces neuroinflammation in traumatic brain injury,” was authored by Hannah Flinn, Austin Marshall, Morgan Holcomb, Marissa Burke, Goknur Kara, Leonardo Cruz-Pineda, Sirena Soriano, Todd J. Treangen & Sonia Villapol.